CAD Designer – Patient Specific Instruments
Treace Medical Concepts, Inc.
Summary
The CAD Designer for Patient Specific Instruments is responsible for generating 3D CAD designs of foot deformity correction and patient-specific cut guides. The designer considers surgeon preferences and works with engineers to model each patient's custom surgical plan. The designer also works with quality and operations to deliver surgical plans and guides on time.
Job description
Position Summary
The CAD Designer for Patient Specific Instruments is responsible for generating 3D CAD designs of foot deformity correction and patient-specific cut guides. The designer considers surgeon preferences and works with engineers to model each patient's custom surgical plan. The designer also works with quality and operations to deliver surgical plans and guides on time.
Primary Duties and Responsibilities
- Check incoming CT scans for image quality and suitability for design
- Segment anatomy and build 3D models using image segmentation software
- Draft pre-operative plans, including deformity correction, resections and alignment for technical review
- Design patient-specific cut guides and related instruments in Solidworks, applying design for additive manufacturing principles
- Work cross-functionally to ensure high-quality and timely production and delivery of custom guides
- Coordinate with Marketing and Medical Education departments to support cadaveric labs
- Suggest process and design automations and provide input on improvement projects
- Ensure compliance with HIPAA and internal quality assurance standards
- Other duties as assigned
Requirements
- Associates degree in engineering (mechanical, design, bioengineering, or biomedical), a comparable technical certification, or equivalent experience
- 2+ years professional experience with 3D CAD software for product development
Company overview
Treace Medical Concepts, Inc. is a commercial-stage orthopedic medical device company headquartered in Ponte Vedra Beach, Florida, that is revolutionizing the surgical treatment of Hallux Valgus, commonly known as bunions. Founded in 2014, the company has pioneered the proprietary Lapiplasty 3D Bunion Correction System, a comprehensive solution combining novel instruments, implants, and surgical methods designed to address the root cause of bunion deformities. Unlike traditional approaches that often result in inconsistent outcomes and high recurrence rates, Treace's technology corrects the metatarsal bone in all three dimensions, providing more stable and reproducible results. The company's product portfolio also includes the Adductoplasty System for midfoot correction, Hammertoe PEEK Fixation System, and SpeedPlate System, all focused on advancing foot and ankle surgical care. Treace went public on the Nasdaq in April 2021 under the ticker symbol TMCI and has established itself as a leader in orthopedic innovation, with its Lapiplasty system receiving FDA 510(k) clearance in 2015 and demonstrating significant clinical success in treating approximately 67 million Americans affected by bunions.